Experimental and clinical evaluation of cardioprotective effects by adenosine and nitric oxide
Experimental and clinical evaluation of cardioprotective effects by adenosine and nitric oxide
批准号:
16390225
负责人:
HORIO Masatsugu
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In the developed country, arrhythmia and subsequent heart failure after myocardial infarction have been major cause of cardiac death. This study was designed to elucidate the mechanism of cardiovascular injury after acute myocardial infarction and develop the novel method to protect myocardial damage after ischemic stress. We especially examined the ischemia preconditioning phenomenon and role of vasodilatation after brief ischemia using rat or canine ischemia model.In this study, we showed that production of NO and K channel opener mimicked ischemic preconditioning. Adenosine was also revealed to have cardioprotective effect after ischemia suggesting adenosine and NO pathway plays an important role of ischemia preconditioning phenomenon. Then we showed that common anti-hypertensive medicine carvedirol and amlodipine protect ischemic injury by vascular dilation via production of NO and adenosine. Intracellular signaling of adenosine and NO was also examined and revealed the involvement of PKC and PKA in this protective effect.Since we concluded that NO and adenosine are key molecules for protecting these ischemic damages, we started the clinical use of adenosine signal enhancer for heart failure. We will continue to examine the effect of adenosine for cardiovascular function in various conditions clinically and experimentally.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1097/00005344-200404000-00013
发表时间:
2004-04-01
期刊:
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
影响因子:
3
作者:
[Asanuma, H, Sanada, S, Kitakaze, M]
通讯作者:
Kitakaze, M
Celiprolol, a vasodilatory bet-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Celiprolol 是一种血管舒张阻滞剂,可抑制小鼠压力超负荷引起的心脏肥大,并通过一氧化氮依赖性机制防止向心力衰竭的转变。
DOI:
--
发表时间:
2004
期刊:
Circulation 110
影响因子:
--
作者:
[Kubo T, Kitaoka H, Okawa M, Matsumura Y, Hitomi N, Yamazaki N, Furuno T, Takata J, Nishinaga M, Kimura A, Doi YL, Liao Yulin]
通讯作者:
Liao Yulin
DOI:
10.1161/01.cir.0000160350.20810.0f
发表时间:
2005-04-05
期刊:
CIRCULATION
影响因子:
37.8
作者:
[Li, Y, Minamino, T, Kitakaze, M]
通讯作者:
Kitakaze, M
Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemiccaninehearts.
β-肾上腺素受体阻滞剂卡维地洛通过腺苷依赖性机制在缺血性犬心脏中提供心脏保护作用。
DOI:
--
发表时间:
2004
期刊:
Circulation 109
影响因子:
--
作者:
[Inagaki N, Hayahsi T, Arimura T, Koga Y, Takahashi M, Shibata H, Teraoka K, Chikamori T, Yamashina A, Kimura A, Liao Yulin, Ogita Hisakazu, Ogita Hisakazu, Sanada Syoji, Sanada Syoji, Shintani Yasunori, Asanuma Hiroshi]
通讯作者:
Asanuma Hiroshi
Paloxifene improves coronary perfusion, cardiac contractility, and myocardial metabolism in the ischemic heart : role of phosphatidylinositol 3-kinase/Akt pathway.
帕洛昔芬改善缺血性心脏中的冠状动脉灌注、心肌收缩力和心肌代谢:磷脂酰肌醇 3-激酶/Akt 途径的作用。
DOI:
--
发表时间:
2004
期刊:
J Cardiovasc Pharmacol 43
影响因子:
--
作者:
[Inagaki N, Hayahsi T, Arimura T, Koga Y, Takahashi M, Shibata H, Teraoka K, Chikamori T, Yamashina A, Kimura A, Liao Yulin, Ogita Hisakazu]
通讯作者:
Ogita Hisakazu
共 15 条
海外基金